articleThe LancetMay 1, 2011Closed access

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

PWPaul W. NobleCACarlo AlberaWZWilliamson Z. BradfordUCUlrich CostabelMKMarilyn K. Glassberg

Duke University · University of Turin · +10 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

2,139
total citations
FWCI
90.57
Percentile
100%
References
38
Citations per year

Authors

12

Topics & keywords

Topics
Keywords
  • Pirfenidone
  • Medicine
  • Idiopathic pulmonary fibrosis
  • Placebo
  • Internal medicine
  • Pulmonary function testing
  • Vital capacity
  • Clinical endpoint
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.